Skip to main content
C

Công ty Cổ phần Y Dược phẩm Vimedimex — Investor Relations & Filings

Ticker · VMD ISIN · VN000000VMD9 HSX Manufacturing
Open in API
Filings indexed 333 across all filing types
Latest filing 2021-12-31 Regulatory Filings
Country VN Viet Nam
Listing HSX VMD

About Công ty Cổ phần Y Dược phẩm Vimedimex

www.vietpharm.com.vn/www.vimedimex2-hcm…

Vimedimex Medi-Pharma Joint Stock Company, established in 1984, is a pharmaceutical enterprise. Initially a state-owned entity, it was privatized in 2006. The company's core activities encompass the import, export, and manufacturing of medical and pharmaceutical products. It contributes to the domestic healthcare sector by supplying medicines and medical equipment, aligning with efforts to promote local production over imported alternatives.

Recent filings

Filing Released Lang Actions
VMD: Thông báo tạm dừng tổ chức ĐHĐCĐ bất thường
Regulatory Filings Classification · 85% confidence The document is a formal notification by the company to securities regulators and shareholders announcing the suspension of an extraordinary general meeting due to COVID-19 directives. It does not contain actual financial data, voting results, or meeting materials, nor is it an AGM presentation or a published report. It is a routine regulatory announcement, which falls under the general “Regulatory Filings” category (RNS).
2021-12-31 Vietnamese
VMD: Nghị quyết HĐQT về việc thông qua tạm dừng tổ chức ĐHĐCĐ bất thường
Regulatory Filings Classification · 85% confidence The document is a formal board resolution (Nghị quyết) by the company’s Board of Directors to postpone convening an extraordinary general shareholders’ meeting due to COVID-19 measures. It does not announce changes in board membership (MANG), disclose financial results (ER/IR/10-K), or solicit proxies (PSI), nor is it a report publication or certification. It is an internal governance action without available specific category, so it falls under the catch–all Regulatory Filings (RNS).
2021-12-31 Vietnamese
VMD: Giải trình thông tin báo chí về việc thu hồi giấy chứng nhận kinh doanh dược tại Hải Phòng
Regulatory Filings Classification · 85% confidence The document is a formal explanatory letter (Giải trình) from Vimedimex to the Ho Chi Minh Stock Exchange clarifying a license revocation rumor and constitutes an unusual event disclosure under stock exchange listing rules. It contains no financial statements or substantive financial data, no proxy or dividend information, no management changes, nor any M&A or capital events. It is a regulatory announcement responding to a request from the exchange and falls under general regulatory filings (RNS).
2021-12-23 Vietnamese
VMD: Nghị quyết HĐQT về việc thông qua thời gian và địa điểm tổ chức ĐHĐCĐ bất thường
Regulatory Filings Classification · 85% confidence The document is a disclosure to the State Securities Commission and HOSE announcing a Board resolution setting the time and place for an Extraordinary General Meeting. It is not the AGM materials themselves, nor a report containing financial data, nor a voting result. It is a miscellaneous regulatory announcement of a corporate action, fitting the catch-all Regulatory Filings (RNS) category.
2021-12-16 Vietnamese
VMD: Nghị quyết HĐQT về việc thông qua thời gian, địa điểm ĐHĐCĐ bất thường
Regulatory Filings Classification · 70% confidence The document is a Board of Directors resolution (Nghị quyết) setting the time and location for an extraordinary shareholders meeting. It is not a financial report, proxy statement or AGM presentation, nor does it announce management changes. It is a corporate/board announcement that falls under general regulatory/filing announcements.
2021-12-16 Vietnamese
VMD: Thông báo nhận được Quyết định 5681/QĐ-BYT vền việc thu hồi giấy chứng nhận đủ điều kiện kinh doanh dược tại Hải Phòng
Regulatory Filings Classification · 90% confidence The document is a corporate announcement filed with the State Securities Commission and Ho Chi Minh Stock Exchange regarding the issuance and subsequent revocation of a pharmaceutical business license for one of the company’s sites due to operational changes. It contains no financial statements, management discussion, or details of share issuance or dividends. It is a general regulatory compliance announcement, fitting the fallback category for miscellaneous regulatory filings.
2021-12-14 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.